Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts: "Transitional Drugs 3". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
21Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 11 active published awards; 11 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published14 May 2025, 19:27 BST | Last source update14 May 2025, 19:27 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-04c9a9 | ||
What is being bought
Drugs which have recently lost their patent exclusivity
What changed
From the official release history
- tender value changed
14 May 2025, 19:27 BST - Status changed to complete
14 May 2025, 19:27 BST - Official notice release published
14 May 2025, 19:27 BST - Submission deadline changed to published date
14 May 2025, 19:27 BST - Buyer information updated
14 May 2025, 19:27 BST - Published value updated to £15,169,777
19 Dec 2024, 14:50 GMT - Status changed to active
19 Dec 2024, 14:50 GMT - Official notice release published
19 Dec 2024, 14:50 GMT - Submission deadline changed to 23 Jan 2025, 12:00 GMT
19 Dec 2024, 14:50 GMT - Buyer information updated
19 Dec 2024, 14:50 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedTransitional Drugs 3Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
14 May 2025, 19:27 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 15 Apr 2025, 00:00 BST · £3,388,055 - Contract active
Signed 15 Apr 2025, 00:00 BST · £1,363,131 - Contract active
Signed 15 Apr 2025, 00:00 BST · £167,141 - Contract active
Signed 15 Apr 2025, 00:00 BST · £3,518,112 - Contract active
Signed 15 Apr 2025, 00:00 BST · £1,140,311 - Contract active
Signed 15 Apr 2025, 00:00 BST · £180,520 - Contract active
Signed 15 Apr 2025, 00:00 BST · £5,963,560 - Contract active
Signed 15 Apr 2025, 00:00 BST · £5,963,558 - Contract active
Signed 15 Apr 2025, 00:00 BST · £7,180,657 - Contract active
Signed 15 Apr 2025, 00:00 BST · £6,580 - Contract active
Signed 15 Apr 2025, 00:00 BST · £174,005
Commercial outcome and competition
Awards Celltrion Healthcare Uk Ltd Not published · Not published · active Tillomed Laboratories Ltd Not published · Not published · active Zentiva Ltd Not published · Not published · active Amgen Ltd Not published · Not published · active Biogen Idec Ltd Not published · Not published · active Celix Pharma Not published · Not published · active Fresenius Kabi Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Sun Pharma Ltd Not published · Not published · active Thornton & Ross Ltd Not published · Not published · active |
Contracts Transitional Drugs 3 £3,388,055 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £1,363,131 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £167,141 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £3,518,112 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £1,140,311 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £180,520 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £5,963,560 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £5,963,558 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £7,180,657 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £6,580 · signed 15 Apr 2025, 00:00 BST · active Transitional Drugs 3 £174,005 · signed 15 Apr 2025, 00:00 BST · active |
Bid statistics bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) |
Buyer and organisations in this procedure
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
Contracting authority GB-FTS-147859Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published